CN1769295B - 使用纯化的抗原特异性抗体快速检测肺炎链球菌的体外方法和材料 - Google Patents

使用纯化的抗原特异性抗体快速检测肺炎链球菌的体外方法和材料 Download PDF

Info

Publication number
CN1769295B
CN1769295B CN2005100847095A CN200510084709A CN1769295B CN 1769295 B CN1769295 B CN 1769295B CN 2005100847095 A CN2005100847095 A CN 2005100847095A CN 200510084709 A CN200510084709 A CN 200510084709A CN 1769295 B CN1769295 B CN 1769295B
Authority
CN
China
Prior art keywords
streptococcus pneumoniae
polysaccharide antigen
cell walls
antigen
purifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2005100847095A
Other languages
English (en)
Chinese (zh)
Other versions
CN1769295A (zh
Inventor
N·J·穆尔
M·K·芬顿
V·A·库奇纳
E·V·莫洛科夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diagnostics Scarborough Inc
Original Assignee
Binax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binax Inc filed Critical Binax Inc
Publication of CN1769295A publication Critical patent/CN1769295A/zh
Application granted granted Critical
Publication of CN1769295B publication Critical patent/CN1769295B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N2021/752—Devices comprising reaction zones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N2021/757—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated using immobilised reagents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N2021/7756—Sensor type
    • G01N2021/7759—Dipstick; Test strip
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G01N2333/3156—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae [Pneumococcus]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN2005100847095A 1998-09-18 1999-09-20 使用纯化的抗原特异性抗体快速检测肺炎链球菌的体外方法和材料 Expired - Lifetime CN1769295B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15648698A 1998-09-18 1998-09-18
US09/156,486 1998-09-18
US09/397,110 1999-09-16
US09/397,110 US6824997B1 (en) 1998-09-18 1999-09-16 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNB998110426A Division CN1214816C (zh) 1998-09-18 1999-09-20 使用纯化的抗原特异性抗体快速检测肺炎链球菌的体外方法和材料

Publications (2)

Publication Number Publication Date
CN1769295A CN1769295A (zh) 2006-05-10
CN1769295B true CN1769295B (zh) 2011-09-14

Family

ID=33449075

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005100847095A Expired - Lifetime CN1769295B (zh) 1998-09-18 1999-09-20 使用纯化的抗原特异性抗体快速检测肺炎链球菌的体外方法和材料

Country Status (3)

Country Link
US (4) US6824997B1 (https=)
JP (2) JP2012006929A (https=)
CN (1) CN1769295B (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080096236A1 (en) * 1998-08-25 2008-04-24 Binax, Inc. Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof
US6824997B1 (en) * 1998-09-18 2004-11-30 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US9134303B1 (en) 1998-08-25 2015-09-15 Alere Scarborough, Inc. ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto
US6916626B1 (en) * 2001-04-25 2005-07-12 Rockeby Biomed Ltd. Detection of Candida
EA200400548A1 (ru) * 2001-10-15 2005-06-30 Чирон Корпорейшн Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
US7718375B2 (en) * 2002-02-27 2010-05-18 Binax, Inc. Modification of bioassays for detection of antigens characteristic of bacteria that are causative of ear and respiratory infections to eliminate false positive results caused by nasopharyngeal colonization of children
EP1692277A4 (en) * 2003-11-26 2008-03-12 Binax Inc METHODS AND NECESSARY FOR PREDICTING INFECTIOUS PATHOLOGY
EP1718972A4 (en) * 2004-02-17 2009-05-27 Binax Inc METHOD AND KITS FOR PROOFING MULTIPLE DISEASES
EP1729791A2 (en) * 2004-03-17 2006-12-13 Chiron Corporation Treatment of severe community-acquired pneumonia by admistration of tissue factor pathway inhibitor (tfpi)
US7387890B2 (en) 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US8153444B2 (en) * 2005-10-13 2012-04-10 Auric Enterprises, Llc Immuno gold lateral flow assay
US7910381B2 (en) * 2005-10-13 2011-03-22 BioAssay Works Immuno gold lateral flow assay
US7344893B2 (en) * 2005-10-13 2008-03-18 Auric Enterprises, Llc Immuno-gold lateral flow assay
US20080014657A1 (en) * 2006-07-12 2008-01-17 Beckton Dickinson And Company Use of Albumin, Bovine, P-Aminophenyl N-Acetyl B-D Glucosaminide as a Control Line for an Immunoassay Device
CN101517095A (zh) * 2006-09-26 2009-08-26 爱科来株式会社 分析用具中的试剂层的形成方法、分析用具的制造方法及分析用具
US8247220B2 (en) * 2008-02-01 2012-08-21 Kimberly-Clark Worldwide, Inc. Optical indicator for detecting bacterial pathogens
JP5509067B2 (ja) 2008-03-31 2014-06-04 大塚製薬株式会社 肺炎球菌検出方法
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
US8821409B2 (en) 2008-12-23 2014-09-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Lung aerosol collection device
EP2544709A4 (en) * 2010-03-12 2014-01-08 Univ Pennsylvania METHOD FOR PREVENTING AND TREATING THE COLONIZATION OF STAPHYLOCOCCUS AUREUS AND THEIR INFECTIOUS DISEASES AND DISEASES
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
US20140377765A1 (en) 2012-03-30 2014-12-25 Otsuka Pharmaceutical Co., Ltd. Method for determining severity of pneumococcal pneumonia
SG11201608278WA (en) 2014-04-02 2016-10-28 Chembio Diagnostic Systems Inc Immunoassay utilizing trapping conjugate
WO2015200626A1 (en) * 2014-06-25 2015-12-30 The Rockefeller University Compositions and methods for rapid production of versatile nanobody repertoires
US20160033505A1 (en) * 2014-07-31 2016-02-04 Laborie Medical Technologies Canada Ulc Mobile Phase Test Strip Components, Conjugate Pad Pre-treatment Solutions, And Related Methods Thereof
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
TWI521063B (zh) 2015-03-10 2016-02-11 國立交通大學 生物感測裝置及分離生物分子的方法
JP6703354B2 (ja) * 2016-08-31 2020-06-03 栄研化学株式会社 非特異反応抑制剤および前処理方法
CN106244560B (zh) * 2016-09-20 2019-07-02 康希诺生物股份公司 一种C-Ps单克隆抗体及其制备和应用
JP6832758B2 (ja) * 2017-03-14 2021-02-24 デンカ株式会社 非特異反応を防止し得る、糖鎖抗原を抽出し測定するためのイムノクロマト試験片
FR3110245B1 (fr) * 2019-05-16 2024-11-29 Univ Jean Monnet Saint Etienne Procede de detection de pneumocoques
CN113063942B (zh) * 2021-03-31 2022-04-29 山东农业大学 一种检测摩氏摩根菌抗体的间接elisa检测试剂盒及应用
CN116804674B (zh) * 2023-08-03 2026-04-21 郑州安图生物工程股份有限公司 一种肺炎链球菌尿抗原elisa试剂盒及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1156826C (zh) * 1998-05-27 2004-07-07 松下电器产业株式会社 光盘装置

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206094A (en) 1976-06-09 1980-06-03 California Institute Of Technology Method for producing a biological reagent
US4411832A (en) 1979-11-26 1983-10-25 Pedro Cuatrecasas Polysaccharide matrices comprising macromolecular spacer arms for use as adsorbents in affinity chromatography techniques
NL8000173A (nl) * 1980-01-11 1981-08-03 Akzo Nv Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4514509A (en) 1981-09-21 1985-04-30 Indiana University Foundation Method for the diagnosis of Legionnaires' disease
US4954449A (en) * 1982-08-24 1990-09-04 The United States Of America As Represented By The Secretary Of The Army Human monoclonal antibody reactive with polyribosylribitol phosphate
FR2541304A1 (fr) 1983-02-21 1984-08-24 Centre Nat Rech Scient Anticorps monoclonaux anti-legionella, procede d'obtention et application au diagnostic de pneumonies
US5059591B1 (en) 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4703017C1 (en) * 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US5807715A (en) * 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
DE3445816C1 (de) * 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
US4888279A (en) * 1984-12-21 1989-12-19 Thomas Jefferson University Novel immunosorbent assays employing antibiotic keying agents
US5879881A (en) * 1985-04-04 1999-03-09 Hybritech, Incorporated Solid phase system for use in ligand-receptor assays
US4751190A (en) * 1985-07-22 1988-06-14 Abbott Laboratories Fluorescence polarization immunoassay and reagents for use therein
TW203120B (https=) * 1985-10-04 1993-04-01 Abbott Lab
DE3856421T2 (de) * 1987-04-27 2000-12-14 Unilever Nv Spezifische Bindungstestverfahren
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US5098827A (en) * 1988-02-26 1992-03-24 The University Of Florida Novel bacterial markers for pathogenic group B streptococci
AU4128089A (en) * 1988-09-15 1990-03-22 Rorer International (Overseas) Inc. Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
US5139933A (en) * 1989-09-26 1992-08-18 Vicam, L.P. Assay method for detecting listeria
US5075078A (en) 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
US5198339A (en) 1990-07-13 1993-03-30 Board Of Regents, The University Of Texas System Method for detection of gram-negative bacterial lipopolysaccharides in biological fluids
NZ239643A (en) 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
US5843463A (en) 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
ES2131066T3 (es) 1990-12-21 1999-07-16 Antex Biolog Inc Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
JP3176659B2 (ja) 1991-09-05 2001-06-18 本田技研工業株式会社 電気自動車
ES2198405T3 (es) * 1991-11-22 2004-02-01 Nabi Biopharmaceuticals Antigenos de superficie de tipo i asociados a staphylococcus epidermis.
WO1993015217A1 (en) * 1992-02-04 1993-08-05 Quidel Corporation Simplified extraction method for bacterial antigens using dried reagents
GB9224584D0 (en) 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
JP3281075B2 (ja) * 1992-12-28 2002-05-13 日本ジーイープラスチックス株式会社 熱可塑性樹脂組成物
WO1994029696A1 (en) * 1993-06-09 1994-12-22 Quidel Corporation Antigen-specific one-step assays
US5455032A (en) * 1993-07-29 1995-10-03 The United States Of America As Represented By The Department Of Health And Human Services Use of phosphocholine hapten conjugates in vaccines
US5415994A (en) * 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
US5367058A (en) 1993-08-25 1994-11-22 Becton, Dickinson And Company Modified antibodies with increased affinity
WO1995031548A1 (en) * 1994-05-16 1995-11-23 The Uab Research Foundation Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
US6057421A (en) * 1994-11-30 2000-05-02 Immpheron, Inc. Variable heavy and light chain regions of murine monoclonal antibody 1F7
US5695768A (en) * 1995-06-07 1997-12-09 Alberta Research Council Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
US6355255B1 (en) * 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
FR2746316B1 (fr) 1996-03-19 1998-06-12 Guerlain Nouvelles compositions cosmetologiques ou dermatologiques
US6245335B1 (en) * 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
ES2206659T3 (es) * 1996-06-07 2004-05-16 Oxoid Limited Dispositivo y kits para probar suero y similares.
AUPO071396A0 (en) 1996-06-28 1996-07-25 Chandler, Howard Milne Chromatographic assay or test device
JP3517808B2 (ja) 1996-07-17 2004-04-12 日本酸素株式会社 気相成長方法及び装置
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US5871951A (en) * 1996-09-23 1999-02-16 The Children's Hospital Of Philadelphia Compositions and methods for treatment of infection caused by Haemophilus influenzae and Streptococcus pneumoniae
US5798273A (en) * 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
US6194221B1 (en) * 1996-11-19 2001-02-27 Wyntek Diagnostics, Inc. Hybrid one-step immunochromatographic device and method of use
US6979576B1 (en) * 1997-07-25 2005-12-27 Shu-Ching Cheng Methods of use of one step immunochromatographic device for Streptococcus A antigen
US6676946B2 (en) * 1997-03-27 2004-01-13 Institut Pasteur Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof
JP3411186B2 (ja) 1997-06-06 2003-05-26 シャープ株式会社 不揮発性半導体記憶装置
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US5989542A (en) * 1997-08-20 1999-11-23 Brigham And Women's Hospital, Inc. Capsular polysaccharides from enterococci
US6303114B1 (en) 1998-03-05 2001-10-16 The Medical College Of Ohio IL-12 enhancement of immune responses to T-independent antigens
US6824997B1 (en) * 1998-09-18 2004-11-30 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
EP1113817B1 (en) * 1998-09-18 2005-04-20 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US6495139B2 (en) * 1998-11-19 2002-12-17 St. Jude Children's Research Hospital Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
GB9902659D0 (en) * 1999-02-05 1999-03-31 Microbiological Res Authority Assay with reduced background
AU4057300A (en) * 1999-03-30 2000-10-16 Board Of Regents, The University Of Texas System Compositions and methods for modifying toxic effects of proteinacious compounds
US7169903B2 (en) * 2001-12-21 2007-01-30 Biosynexus Incorporated Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
US7718375B2 (en) * 2002-02-27 2010-05-18 Binax, Inc. Modification of bioassays for detection of antigens characteristic of bacteria that are causative of ear and respiratory infections to eliminate false positive results caused by nasopharyngeal colonization of children
US20060121058A1 (en) * 2002-08-08 2006-06-08 Children's Medical Center Corporation Anti-pneumococcal preparations
AU2003298770A1 (en) * 2002-12-02 2004-06-23 Biosynexus Inc Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
WO2008022299A1 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Diagnosing pneumococcal pneumonia
CN101021526B (zh) * 2007-03-16 2012-01-25 艾博生物医药(杭州)有限公司 一种直观显示检测结果的装置和方法
JP5509067B2 (ja) * 2008-03-31 2014-06-04 大塚製薬株式会社 肺炎球菌検出方法
CN110859957B (zh) * 2014-01-21 2024-04-12 辉瑞公司 包含缀合荚膜糖抗原的免疫原性组合物及其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1156826C (zh) * 1998-05-27 2004-07-07 松下电器产业株式会社 光盘装置

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LARRY G.BENNETT等，.Binding studies with antibodiew having phosphorylcholinespecificity and fragments derived from their homologousstreptococcus pneumoniae type 27 capsular pholysaccharide".the journal of immunology122 6.1979,122(6),2356.
LARRY G.BENNETT等,.Binding studies with antibodiew having phosphorylcholinespecificity and fragments derived from their homologousstreptococcus pneumoniae type 27 capsular pholysaccharide".the journal of immunology122 6.1979,122(6),2356. *

Also Published As

Publication number Publication date
JP2015180880A (ja) 2015-10-15
JP2012006929A (ja) 2012-01-12
US20080241191A1 (en) 2008-10-02
US6824997B1 (en) 2004-11-30
JP5969088B2 (ja) 2016-08-10
US9310369B2 (en) 2016-04-12
US20150219648A1 (en) 2015-08-06
CN1769295A (zh) 2006-05-10
US9921220B2 (en) 2018-03-20
US20160377614A1 (en) 2016-12-29

Similar Documents

Publication Publication Date Title
CN1769295B (zh) 使用纯化的抗原特异性抗体快速检测肺炎链球菌的体外方法和材料
US20070265433A1 (en) Process and Materials for the Rapid Detection of Streptococcus Pneumoniae Employing Purified Antigen-Specific Antibodies
Gray et al. Laboratory diagnosis of bacterial meningitis
Neter Bacterial hemagglutination and hemolysis
Leinonen et al. Comparison of counter-current immunoelectrophoresis, latex agglutination, and radioimmunoassay in detection of soluble capsular polysaccharide antigens of Haemophilus influenzae type b and Neisseria meningitidis of groups A or C.
Baker et al. Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus
Bartram et al. Diagnosis of bacterial diseases by detection of serum antigens by counterimmunoelectrophoresis, sensitivity, and specificity of detecting Pseudomonas and pneumococcal antigens
Edwards et al. Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination
Guirguis et al. Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78
Fransén et al. Bacteria and serologic reactions against bacteria in patients hospitalized with acute respiratory illness
US20120135420A1 (en) Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
Parish Studies on vasculitis: III. Decreased formation of antibody to M protein, group A polysaccharide and to some exotoxins, in persons with cutaneous vasculitis after streptococcal infection
Levine et al. Generic protocol for population-based surveillance of Haemophilus influenzae type B
Finkelstein et al. Rapid latex particle agglutination test for Escherichia coli strains of porcine origin producing heat-labile enterotoxin
EP1259249B1 (en) Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
MXPA01002822A (en) Process and materials for the rapid detection of streptococcus pneumoniae
Knigge et al. Enzyme immunoassay for the detection of group A streptococcal antigen
Edberg Conventional and molecular techniques for the laboratory diagnosis of infections of the central nervous system
Danielsson et al. Chapter XII Serotyping and Antigenic Studies of Neisseria gonorrhoeae
Prixová et al. On the participation of antibodies and complement in the antibacterial activity of an extract from rabbit polymorphonuclear leucocytes
AU2001241867A1 (en) Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
Hasan Development of rapid methods and test kits for detection of Vibrio cholerae 01
Kalhan et al. In Groups I and IV, fever was the presenting symptom in all the children. Gastrointestinal tract disturbances like diarrhea and abdominal pain were present
JPS62502284A (ja) 抗原的に活性な蛋白質及び淋病の診断におけるその使用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: ALERE SCARBOROUGH, INC.

Free format text: FORMER OWNER: BINAX INC.

Effective date: 20120719

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20120719

Address after: The United States, Paul of Maine City South Gate Road, No. 10

Patentee after: Alere Scarborough Inc.

Address before: Maine

Patentee before: Binax Inc.

CX01 Expiry of patent term

Granted publication date: 20110914

CX01 Expiry of patent term